Fig. 2From: The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic dataSchematic representations of significant deregulated genes.- Distribution of the 6652 deregulated genes. Significant deregulation was bases on fold changes > 1.5 (up-regulation) or < 1.5 (down-regulation) with respect to expression values in DN control samplesBack to article page